RALI-DX Trademark

Trademark Overview

On Wednesday, May 6, 2020, a trademark application was filed for RALI-DX with the United States Patent and Trademark Office. The USPTO has given the RALI-DX trademark a serial number of 88902990. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Saturday, September 23, 2023. This trademark is owned by SQI Diagnostics Systems Inc.. The RALI-DX trademark is filed in the Pharmaceutical Products category with the following description:

Medical diagnostic assay kits comprising a multiplexed biomarker assay for testing body fluids that measure inflammation in a patient
rali-dx

General Information

Serial Number88902990
Word MarkRALI-DX
Filing DateWednesday, May 6, 2020
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateSaturday, September 23, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesMedical diagnostic assay kits comprising a multiplexed biomarker assay for testing body fluids that measure inflammation in a patient

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 9, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSQI Diagnostics Systems Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressToronto, Ontario M9W1A4
CA

Trademark Events

Event DateEvent Description
Monday, September 25, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Saturday, September 23, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Saturday, September 23, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Sunday, May 28, 2023NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Sunday, May 28, 2023INQUIRY TO SUSPENSION E-MAILED
Sunday, May 28, 2023SUSPENSION INQUIRY WRITTEN
Thursday, April 6, 2023SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Wednesday, September 14, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, September 14, 2022LETTER OF SUSPENSION E-MAILED
Wednesday, September 14, 2022SUSPENSION LETTER WRITTEN
Wednesday, September 14, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 14, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 14, 2022ASSIGNED TO LIE
Thursday, August 11, 2022TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Sunday, February 13, 2022NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Sunday, February 13, 2022INQUIRY TO SUSPENSION E-MAILED
Sunday, February 13, 2022SUSPENSION INQUIRY WRITTEN
Friday, November 12, 2021SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Monday, November 8, 2021ASSIGNED TO EXAMINER
Friday, September 17, 2021SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Wednesday, February 17, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, February 17, 2021LETTER OF SUSPENSION E-MAILED
Wednesday, February 17, 2021SUSPENSION LETTER WRITTEN
Tuesday, February 9, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 8, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 8, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 10, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 10, 2020NON-FINAL ACTION E-MAILED
Monday, August 10, 2020NON-FINAL ACTION WRITTEN
Saturday, August 1, 2020ASSIGNED TO EXAMINER
Monday, May 18, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, May 9, 2020NEW APPLICATION ENTERED

Related Keywords

rali assay fluids body measure inflammation patient testing biomarker diagnostic kits